Brenda Chahla/X
Nov 24, 2024, 13:13
Brenda Chahla: Honored to have presented our research on Pembrolizumab in ACC at the 9th International Adrenal Cancer Conference
Brenda Chahla, Postdoctoral Fellow at MD Anderson Cancer Center, shared a post on X:
“Very honored to have presented our research project ‘Phase lI Clinical Trial of Single-Agent Pembrolizumab in ACC’, mentored by Mouhammed Amir Habra and Matthew Campbell, at the 9th Int’l Adrenal Cancer Conference.
In this fight together!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 23, 2024, 16:19
Dec 23, 2024, 15:26
Dec 23, 2024, 15:13
Dec 23, 2024, 15:10